The Valley Desk

NCT01713946 · Interventional trial

A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures

Overall registry status Completed

Phase 3

Conditions Tuberous Sclerosis Complex-associated Refractory Seizures

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov